Trending

Global Antisense & RNAi Therapeutics Market Forecast And Growth Through COVID-19, Competitive Landscape, Segments, Key Regions Overview

The Business Research Company’s ‘Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030’ is the most comprehensive report available on this market. It covers 60 geographies and thus helps gain a truly global perspective of the market. The regional and country breakdowns section gives an analysis of the market in each geography as well as the size of the market by region and by country. It also compares the market’s historic and forecast growth while highlighting important trends and strategies that template market players can adopt.

The global antisense and RNAi therapeutics market reached a value of nearly $3,677.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 38.2% since 2017. The market is expected to grow from $3,677.3 million in 2020 to $5,660.6 million in 2025 at a rate of 9.0%. The growth is mainly due to the growing demand for antisense and RNAi therapeutics due to COVID-19 which is expected to drive the demand for antisense and RNAi therapeutics. The market is expected to grow to $8,261.2 million in in 2030 at a CAGR of 7.9%.

Request For The Sample Of The Antisense & RNAi Therapeutics Market Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3925&type=smp

The antisense and RNAi therapeutics market consists of sales of antisense and RNAi therapeutics by entities (organizations, sole traders, and partnerships) that develop and manufacture antisense and RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various diseases including cancer, infectious diseases, cardiovascular diseases, genetic disorders, respiratory disorders, and neurological disorders.

Place A Direct Purchase Order Of The Antisense & RNAi Therapeutics Report Here:

https://www.thebusinessresearchcompany.com/report/antisense-rnai-therapeutics-market

The antisense & rnai therapeutics market report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Some of the major players of the antisense & rnai therapeutics market are Biogen Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Moderna, Inc.

The antisense and RNAi therapeutics market is segmented by technology, by route of administration, by indication and by geography.
Segmentation by Technology
The report provides the following market segmentation by technology.
The antisense and RNAi therapeutics market is segmented by technology into

    • a) By RNA Interference
    • b) Antisense RNA

Segmentation by Route of Administration
The antisense and RNAi therapeutics market is also segmented by route of administration into:

    • a) Intravenous injections
    • b) Intra Dermal injunctions
    • c) Other delivery methods

Segmentation by Indication
The antisense and RNAi therapeutics market is also segmented by indication into:

    • a) Oncology
    • b) Cardiovascular device
    • c) Respiratory disorders
    • d) Neurological disorders
    • e) Infectious disease
    • f) Other diseases

Read More On The Global Antisense & RNAi Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/antisense-rnai-therapeutics-market

The antisense & rnai therapeutics market report describes and explains the global antisense & rnai therapeutics market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The antisense & rnai therapeutics report evaluates the market across each region and for the major economies within each region.

The countries covered in the global antisense & rnai therapeutics market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global antisense & rnai therapeutics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Full Report Includes

  1. Executive Summary
  2. Report Structure
  3. Antisense & RNAi Therapeutics Market Characteristics
  4. Antisense & RNAi Therapeutics Market Product Analysis
  5. Antisense & RNAi Therapeutics Market Supply Chain

…..

  1. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
  2. Market Background: Machinery Manufacturing Market
  3. Recommendations
  4. Appendix
  5. Copyright And Disclaimer

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database

The Business Research Company’s flagship product, Global Market Model is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Blog: http://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Source
The Business Research Company

Oliver

Oliver Guirdham (Managing Director) The Business Research Company Europe: +44 207 1930 708 Americas: +1 315 623 0293 Email: info@tbrc.info

Related Articles

Back to top button